MS Surgery resident at SRN Hospital found dead under suspicious circumstances

Prayagraj: In an unfortunate incident, a second-year postgraduate resident doctor in the department of surgery at Swaroop Rani Nehru (SRN) Hospital, Prayagraj, died under suspicious circumstances late Sunday night, police said.  …

Continue ReadingMS Surgery resident at SRN Hospital found dead under suspicious circumstances

Fake bills, forged documents: CBI registers FIR against doctors, hospitals in ECHS fraud

Chandigarh: In a major crackdown, the Central Bureau of Investigation (CBI) has unearthed a multi-crore fraud involving fraudulent medical reimbursement claims under the Ex-Servicemen Contributory Health Scheme (ECHS).  As per…

Continue ReadingFake bills, forged documents: CBI registers FIR against doctors, hospitals in ECHS fraud

Eris Lifesciences Introduces DEMELAN® NEXA Serum: Next-Generation Melanophagy-Focused Approach for Melasma Management in India

Recognizing the evolving understanding of pigmentation biology, Eris Lifesciences has launched DEMELAN® NEXA Serum, a next-generation melanophagy-focused brightening serum designed for the comprehensive management of recurrent melasma, and photo-aging. DEMELAN® NEXA…

Continue ReadingEris Lifesciences Introduces DEMELAN® NEXA Serum: Next-Generation Melanophagy-Focused Approach for Melasma Management in India

EMPEROR-Preserved Score Predicts Outcomes and Identifies Greater Absolute Benefit with Finerenone

In the FINEARTS-HF Trial, the EMPEROR-Preserved Trial risk score showed broad applicability across outcomes. While baseline risk did not alter the relative treatment effect of Finerenone, higher-risk patients derived greater…

Continue ReadingEMPEROR-Preserved Score Predicts Outcomes and Identifies Greater Absolute Benefit with Finerenone

Tirzepatide Lowers Cardiovascular and Kidney Events vs Dulaglutide in High-Risk Diabetes: Study

In a new post hoc analysis, tirzepatide was associated with a lower incidence of a composite cardiovascular and kidney outcome compared with Dulaglutide in patients with diabetes and established cardiovascular…

Continue ReadingTirzepatide Lowers Cardiovascular and Kidney Events vs Dulaglutide in High-Risk Diabetes: Study